TickerGuard
Buy Day today: Poor (44) Weak market breadth · today: Core PCE (August) ≈
RAPP

Rapport Therapeutics, Inc.

Healthcare · Biotechnology

34.10$ -17.7% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Income Statement

All figures per share in USD.

Tick rows to compare them in a chart (up to 4)

Income Statement RAPP
Line item 2022 2023 2024 2025
– 0.00 0.00 0.00
0.00 0.01 0.04 0.02
0.00 -0.01 -0.04 -0.02
0.45 1.55 2.94 2.02
0.07 0.45 1.07 0.65
0.51 2.00 4.00 2.66
-0.52 -2.00 -4.00 -2.66
0.01 0.00 – –
-0.53 -1.92 -3.78 -2.37
– 0.00 – –
-0.53 -1.92 -3.78 -2.37
-0.51 -1.99 -3.96 -2.64

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?